Better methods and estimates of infectious disease burden

Better estimates of infectious disease burden are needed for effective planning and prioritizing of limited public health resources. These are the conclusions of a new Policy Forum article in this week's PLoS Medicine, in which Mirjam Kretzschmar from the Centre for Infectious Disease Control, RIVM in Bilthoven, The Netherlands and colleagues describe the Burden of Communicable Diseases in Europe (BCoDE) study that uses a pathogen-based incidence approach to generate infectious disease burden estimates in Europe taking into full account all chronic and long-term sequelae that can be causally related to an infectious agent.

The authors found that this methodology has the advantage of consistently attributing the burden to its infectious cause. Although the approach also has some limitations—for example, many pathogens cause broad, nonspecific disease syndromes and it is difficult to attribute morbidity to a specific pathogen.

The researchers say that the study's findings show the need for further research in this area and that future challenges include the integration of demographic changes and infection dynamics into the methodology for estimating the burden of IDs.

More information: Kretzschmar M, Mangen M-JJ, Pinheiro P, Jahn B, Fe`vre EM, et al. (2012) New Methodology for Estimating the Burden of Infectious Diseases in Europe. PLoS Med 9(4): e1001205. doi:10.1371/journal.pmed.1001205

add to favorites email to friend print save as pdf

Related Stories

Health varies widely across different regions of Mexico

Jun 17, 2008

A new study of the burden of disease and injury across Mexico has found that the south suffers the highest rates of infectious and nutritional diseases, injuries, and non-communicable diseases. The study, by researchers at ...

Illness thrives in maturing nations

Nov 10, 2010

A three-pronged health challenge is putting the squeeze on already-scarce resources in the developing world, with heart disease, diabetes, and other chronic ailments growing. At the same time, the threat from ...

Estimating global malaria incidence

Dec 20, 2011

Estimates of malaria incidence derived from routine surveillance data suggest that 225 million episodes of malaria occurred worldwide in 2009. This estimate is lower than other published figures, such as those from the Malaria ...

Recommended for you

Global impact of the Ebola outbreak

7 minutes ago

The Ebola virus has been spreading in West Africa since March, but the current outbreak over the past few weeks has reached new heights and elevated the crisis. More than 650 people have died, and in recent days it was learned ...

S.Korea detects second foot-and-mouth case

2 hours ago

South Korea on Monday reported its second case of foot-and-mouth disease in less than a week, triggering fearful memories of a devastating 2011 outbreak that forced the culling of millions of livestock.

Ebola kills Liberian doctor, 2 Americans infected

2 hours ago

(AP)—One of Liberia's most high-profile doctors has died of Ebola, officials said Sunday, and an American physician was being treated for the deadly virus, highlighting the risks facing health workers trying ...

Hepatitis C virus genotype 1 is most prevalent worldwide

3 hours ago

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journa ...

1 in 3000 blood donors in England infected with hepatitis E

3 hours ago

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around ...

Biologic treatments for RA carry similar infection risk

3 hours ago

(HealthDay)—The risk of hospitalized bacterial infections in older rheumatoid arthritis (RA) patients is similar for rituximab or abatacept compared to etanercept, although it is higher for infliximab, ...

User comments